| The market has been very unpredictable due to coronavirus but 2020 is far from over! Early stage medtech companies could be the new hot ticket this year... Let us explain why the buzz is all around medtech stocks right now. If there is one thing the coronavirus did is teach us just how important healthcare and medical devices are. Think about the ventilator shortage the world has seen. The coronavirus panic market selloff has also given investors a chance to buy medical-device stocks and other med-tech plays at a significant discount. Medical devices are essential for safe and effective prevention, diagnosis, treatment and rehabilitation of illness and disease. There is an ever-widening gap between demand for and supply of healthcare and when you consider the rapid ageing of populations in the US, Europe, China, Japan, and many other countries in the world, the market is HUGE!
There is a fruitful hunting ground for medtech stocks that could have astonishing returns and what if we told you that we think we found one? This is a medtech stock that has been flying under the radar at penny stock prices! The company has medical devices that big board players could be scrambling to get a hold of. Players like Quest Diagnostics that has a massive market cap of over $10 billion! This is a company that could also be releasing FDA news any day about potential approval on one of its revolutionary devices. Do you think the company will remain at penny stock prices if it gets FDA approval?? Probably not! The fact that this stock also has one of the smallest trading floats we have ever seen is something to pay close attention to. Low float stocks have seen gains in the hundreds of percents out of nowhere just because demand suddenly hit. Led by industry veterans and devices that could be game changers in the health-care industry, this penny stock company could be getting ready for a major breakout!
This is a paid advertisement. IR Pub LLC is publishing this advertisement, and IR Pub LLC is not offering (and is not responsible for) the product or service being advertised, and is not recommending or endorsing it. IR Pub LLC, the publisher of the advertisement, or one of its affiliates, is the owner of the ChartExperts.com domain (collectively, the “Company” or “we” used herein). The Company bears no responsibility or control over the content of the advertisement and/or the product or service offered.
Compensation Disclosure
IR Pub received thirty thousand dollars paid by Viewergy LLC, a 3rd Party, for brand awareness, marketing distribution and investor education marketing of Cardiol for a period of 2 days. iR Pub has not received any shares or owns any shares of Cardiol. For a full disclaimer | disclosure please click here: https://irpub.com/Disclaimers_Disclosures.php
The Company is a publisher that publishes impersonal views which are not adapted to any specific person, portfolio or need. You understand that no content published as part of the information provided herein constitutes a recommendation that any product, service, particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person. You further understand that none of the creators, providers or publishers of the information contained in this advertisement, or their affiliates, will advise you personally concerning the nature, potential, value or suitability of the product, service, any particular investment, security, portfolio of securities, transaction, investment strategy or other matter. The information herein is provided and should be considered only for general informational purposes only and should not be considered or relied upon as investment advice. The Company is a publisher only, and is not a securities broker or dealer, nor is the Company an investment advisor. To the extent that any of the information published as part of this advertisement may be deemed to be investment advice, such information is general and impersonal and not tailored to the investment needs of any specific person.
There is a very high degree of risk involved in trading securities. Past results are not indicative of future returns. The Company and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The views published in this advertisement are for educational purposes only and should not be construed as investment advice. The information contained in this advertisement, including any observations depicted herein, is obtained from sources believed to be reliable, but the Company does not warrant and there is no guarantee of its completeness or accuracy. Any information expressed herein is based upon interpretations of the information from sources outside of the Company. The Company has not verified the truthfulness of the information. There is no warranty or guarantee of any results, outcome or profit from your use of the information expressed herein. We and our affiliates are not under any obligation to update or correct any information provided on this website. All statements in this advertisement are subject to change without notice. Your use of the information is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. Past performance is not indicative of future results. You should be aware of the real risk of loss in following any views discussed on this website or in the Company’s emails. The views discussed may change as products fluctuate in price or value, and we will not update you on any change in the views published. Investors may get back less than invested. Views mentioned on this website or the Company’s emails may not be suitable for you. The material in this advertisement does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding views mentioned on this website or emails. Before acting on information on this website or emails, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. You must assess the risk of any trade with your advisor and make your own independent decisions regarding any information mentioned herein.
The information contained herein is not furnished in connection with a sale or offer to sell securities or in connection with the solicitation of an offer to buy securities. Our Company, including our affiliates, may have a position or effect transactions in the securities described herein (or options thereon) and may make purchases or sales of these securities while this advertisement is in circulation. We also may employ trading strategies that may be consistent or inconsistent with the strategies provided or discussed herein.
This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by Chart Experts and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past results are not indicative of future returns. Chart Experts and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. By downloading this book your information may be shared with our educational partners. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of Chart Experts may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. |
2020年4月30日星期四
The Next Medtech Stock Poised to Skyrocket
This email was sent to its028@gmail.com by Chart Experts
订阅：
博文评论 (Atom)
没有评论:
发表评论